Foghorn Therapeutics

FHTX64

$7.87arrow_drop_up2.20%$0.16

FHTX64

$7.87

arrow_drop_up2.20%$0.16

Performance History

Key Stats
Open	$7.83
Prev. Close	$7.72
EPS	-1.85
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	7.26	8.19
52 Week Range	2.70	10.25

Ratios







EPS	-1.85

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Foghorn Therapeutics (FHTX)

Foghorn Therapeutics Inc (FHTX) is a biotechnology company specializing in developing therapeutics that regulate the vital cellular components known as chromatin. The company focuses on harnessing the power of these components to modulate gene expression and address various diseases. Foghorn Therapeutics has developed a unique proprietary platform called Gene Traffic Control, which enables the discovery and development of small molecule therapeutics targeting chromatin regulatory pathways. With its innovative approach, the company aims to make a meaningful impact on patients' lives and improve treatment outcomes.

As of the latest available data, the stock price of Foghorn Therapeutics Inc (FHTX) has shown a steady growth trajectory. The company's stock has been performing well in the market, reflecting investor confidence and interest in its unique approach to therapeutics. Investors can keep track of the stock's price fluctuations through various financial platforms or brokerage services that provide real-time stock quotes for FHTX.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Adrian H. B. Gottschalk
Headquarters: Cambridge
Employees: 161
Exchange: NASDAQ

Keep an eye on Foghorn Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Foghorn Therapeutics 's (FHTX) price per share?

The current price per share for Foghorn Therapeutics (FHTX) is $7.88. The stock has seen a price change of $0.17 recently, indicating a 2.2% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Foghorn Therapeutics (FHTX)?

For Foghorn Therapeutics (FHTX), the 52-week high is $10.25, which is 30.16% from the current price. The 52-week low is $2.7, the current price is 191.67% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Foghorn Therapeutics (FHTX) a growth stock?

Foghorn Therapeutics (FHTX) has shown an average price growth of -3.66% over the past three years. It has received a score of 42 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Foghorn Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Foghorn Therapeutics (FHTX) stock price performance year to date (YTD)?

As of the latest data, Foghorn Therapeutics (FHTX) has a year-to-date price change of 22.09%. Over the past month, the stock has experienced a price change of 3.35%. Over the last three months, the change has been -1.69%. Over the past six months, the figure is 31.03%.

help

Is Foghorn Therapeutics (FHTX) a profitable company?

Foghorn Therapeutics (FHTX) has a net income of -$98.43M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -305.48% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $34.16M, with a revenue growth rate of 77.63%, providing insight into the company's sales performance and growth. Operating income is noted at -$107.91M. Furthermore, the EBITDA is -$98.53M.

help

What is the market capitalization of Foghorn Therapeutics (FHTX)?

Foghorn Therapeutics (FHTX) has a market capitalization of $435.85M. The average daily trading volume is 7.94, indicating the stock's liquidity and investor engagement.